Signal active
Investment Firm
Overview
Incept is an effective vehicle for promotion and advancement of technology innovation and entrepreneurship with a primary focus in the life-sciences space, and occasional involvement in unique and select information-technology opportunities, where Incept’s management and financing depth is found to be transferable to the IT space. Incept’s mission is to innovate leadership product lines, meeting the important unmet technological needs of the medical technology space while cultivating leaders who build superb companies focused on growth and creation of shareholder value.
Highlights
1998
1-10
6
1
3
Late Stage Venture, Early Stage Venture
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Incept LLC, established in 1998 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Health Care, Medical Device, Financial Services, Venture Capital, Finance, Biotechnology, Medical, Precision Medicine, Health Diagnostics, Business Development. The organization boasts a portfolio of 6 investments, with an average round size of $27.8M and 3 successful exits. Their recent investments include Nellix, Essex Woodlands Healthcare Partners, Apama Medical, ONSET Ventures, Ascension Ventures. The highest investment round they participated in was $12.8B. Among their most notable exits are Nellix and Essex Woodlands Healthcare Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
6
0
1
3
Investments
6
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Nov 16, 2016 | Apama Medical | Biotechnology | 13.0M |
Oct 23, 2017 | Claret Medical | Health Care | 14.5M |
Dec 10, 2019 | Imperative Care | Health Care | 85.0M |
Aug 15, 2023 | - | - | 30.0M |
Exits
3
Funding Timeline
6
0
0
Funding Rounds
6
Incept LLC has raised 6 rounds. Their latest funding was raised on Aug 15, 2023 from a Series C - Instylla round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Nov 16, 2016 | Series C - Apama Medical | - | 13.0M | - |
Oct 23, 2017 | Series C - Claret Medical | - | 14.5M | - |
Dec 10, 2019 | Series C - Imperative Care | - | 85.0M | - |
Aug 15, 2023 | Series C - Instylla | - | 30.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.